医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NEWS > Home > > 疾病 > AIDS >

AHF Mourns Loss of 100+ AIDS Advocates in Malaysian Airlines Tragedy

2014年07月18日 PM02:33
このエントリーをはてなブックマークに追加


 

LOS ANGELES

AIDS Healthcare Foundation (AHF) mourns the loss of over 100 HIV/AIDS advocates and their families who died Thursday when Malaysian Airlines flight MH17 crashed in Ukraine near the Russian border after apparently being shot down by a missile. Many aboard the doomed flight, including former President of the International AIDS Society Dr. Joep Lange, were en route to the 20th International AIDS Conference in Melbourne, Australia, which begins Sunday.

“To have so many people who have crossed the globe devoting their lives to helping humanity cut down in this fashion is an unspeakable tragedy,” said Michael Weinstein, President of AIDS Healthcare Foundation. “Our heart breaks for their families and loved ones.”

About AHF

AIDS Healthcare Foundation (AHF) is the largest non-profit HIV/AIDS healthcare provider in the USA. AHF currently provides medical care and/or services to over 319,000 individuals in 34 countries worldwide in the US, Africa, Latin America/Caribbean, Eastern Europe, and Asia. For more information, visit www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @AIDSHealthcare.

CONTACT

AIDS Healthcare Foundation
Ged Kenslea, +1.323.308.1833
Mobile
323.791.5526
ged.kenslea@aidshealth.org
or
Kyveli
Diener
, +1.323.960.4846
Mobile 310.779.4796
kyveli.diener@aidshealth.org

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer
  • Seagen and Astellas Announce Presentation of Results from PADCEV® (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced Urothelial Cancer Who Were Ineligible for Cisplatin Chemotherapy
  • No Dogs Left Behind Meat Market Survivors Coming Home
  • Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease
  • Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据